ANTIBODIES

Contributor Information
- Institute Absolute Antibody; University of Oxford
Tool Details
- Tool name: Anti-CD9 [P1/33/2] rAb
- Alternate names: CD9 Molecule; Cell Growth-Inhibiting Gene 2 Protein; Motility Related Protein-1; Leukocyte Antigen MIC3; CD9 Antigen (P24); Tetraspanin-29; 5H9 Antigen; TSPAN29; MRP-1
- Clone: P1/33/2
- Tool type: Antibodies
- Tool sub-type: Primary antibody
- Class: Recombinant
- Conjugate: Unconjugated
- Reactivity: Human
- Host: Mouse
- Description: CD9 antigen is a glycoprotein expressed on the surface of developing B lymphocytes, platelets, monocytes, eosinophils, basophil, stimulated T lymphocytes and neurons and glial cells in the peripheral nervous system. CD9 mediates platelet aggregation and activation via FcgRIIa. It may play a role in cell migration.Antibodies against CD9 have utility in characterisation of acute leukaemias and in some cases AML and for functional studies on platelets
- Immunogen: Acute lymphoblastic leukaemia cells
- Isotype: IgG1
- Research area: Cancer; Tissue-specific biology; Cell biology; Developmental biology; Immunology; Stem cell biology
- For Research Use Only
Target Details
- Target: CD9
- Target background: CD9 antigen is a glycoprotein expressed on the surface of developing B lymphocytes, platelets, monocytes, eosinophils, basophil, stimulated T lymphocytes and neurons and glial cells in the peripheral nervous system. CD9 mediates platelet aggregation and activation via FcgRIIa. It may play a role in cell migration.Antibodies against CD9 have utility in characterisation of acute leukaemias and in some cases AML and for Fn studies on platelets
Application Details
Handling
- Format: Liquid
- Shipping conditions: Shipping at 4°C
References
- • CXCR6, a newly defined biomarker of tissue-specific stem cell asymmetric self-renewal, identifies more aggressive human melanoma cancer stem cells.
- • Jennings et al. 1993. CD9 cluster workshop report: cell surface binding and Fn analysis. In Schlossman SF, et al (eds) Leucocyte Typing V, Vol 2, Oxford University Press, Oxford, New York and Tokyo, p 1249-51
- • Taghizadeh et al. 2010. PLoS One. 5(12):e15183. PMID: 21203549.